Spots Global Cancer Trial Database for portal vein tumor thrombus
Every month we try and update this database with for portal vein tumor thrombus cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients | NCT00849264 | Hepatocellular ... Portal Vein Tum... | chemotherapy wi... treatment with ... treatment with ... | 30 Years - 60 Years | Eastern Hepatobiliary Surgery Hospital | |
| Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion | NCT01850368 | Hepatocellular ... Portal Vein Tum... | Stereotactic ab... | 20 Years - | Korea Cancer Center Hospital | |
| A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis | NCT03178656 | Portal Vein Tum... | Sorafenib surgery | 20 Years - 75 Years | Huazhong University of Science and Technology | |
| HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT | NCT04618367 | Carcinoma, Hepa... Liver Neoplasms Sintilimab Portal Vein Tum... | Hepatic arteria... Lenvatinib Sintilimab | 18 Years - 75 Years | Sun Yat-sen University | |
| Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus | NCT02724475 | Hepatocellular ... Laser Ablation Portal Vein Tum... | LA 3D-CRT | 17 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion | NCT01850368 | Hepatocellular ... Portal Vein Tum... | Stereotactic ab... | 20 Years - | Korea Cancer Center Hospital | |
| A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection | NCT03914352 | Hepatocellular ... | PD-1 antibody TACE | 18 Years - 75 Years | Cancer Hospital of Guangxi Medical University | |
| Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus | NCT04319484 | Hepatocellular ... Portal Vein Tum... Liver Transplan... | lenvatinib Placebo | 1 Year - 75 Years | RenJi Hospital | |
| HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL) | NCT06210334 | Hepatocellular ... | Tislelizumab Lenvatinib | 18 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
| Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT | NCT04127396 | Carcinoma, Hepa... Portal Vein Tum... | Lenvatinib Pill Transarterial c... Sorafenib Transarterial c... | 18 Years - 75 Years | Beijing Ditan Hospital | |
| Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus | NCT01600196 | Hepatocellular ... | Liver resection... | 18 Years - 75 Years | Sun Yat-sen University | |
| TACE Combined With Iodine-125 Seeds Implantation for HCC | NCT03322280 | Hepatocellular ... Portal Vein Occ... Tumor Thrombus | TACE combined w... TACE | 18 Years - 75 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT | NCT04127396 | Carcinoma, Hepa... Portal Vein Tum... | Lenvatinib Pill Transarterial c... Sorafenib Transarterial c... | 18 Years - 75 Years | Beijing Ditan Hospital | |
| TACE Combined With Iodine-125 Seeds Implantation for HCC | NCT03322280 | Hepatocellular ... Portal Vein Occ... Tumor Thrombus | TACE combined w... TACE | 18 Years - 75 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus | NCT02724475 | Hepatocellular ... Laser Ablation Portal Vein Tum... | LA 3D-CRT | 17 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients | NCT00849264 | Hepatocellular ... Portal Vein Tum... | chemotherapy wi... treatment with ... treatment with ... | 30 Years - 60 Years | Eastern Hepatobiliary Surgery Hospital | |
| Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus | NCT04069949 | Unresectable He... Portal Vein Tum... | sorafenib; tori... | 18 Years - 74 Years | Sichuan University | |
| Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus | NCT04069949 | Unresectable He... Portal Vein Tum... | sorafenib; tori... | 18 Years - 74 Years | Sichuan University | |
| Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus | NCT02971345 | Hepatocellular ... Portal Vein Tum... | Stent and Iodin... Stent Iodine-125 seed Epirubicin Ultra-fluid lip... Gelatin sponge ... | 18 Years - 70 Years | Shanghai Zhongshan Hospital | |
| Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT | NCT04169399 | Hepatocellular ... | Toripalimab Stereotactic bo... | 18 Years - 75 Years | Sun Yat-sen University | |
| Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus | NCT02724475 | Hepatocellular ... Laser Ablation Portal Vein Tum... | LA 3D-CRT | 17 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients | NCT00849264 | Hepatocellular ... Portal Vein Tum... | chemotherapy wi... treatment with ... treatment with ... | 30 Years - 60 Years | Eastern Hepatobiliary Surgery Hospital | |
| Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus | NCT06040177 | Hepatocellular ... Portal Vein Tum... Immune Checkpoi... | Cadonilimab Stereotactic ra... Renvatinib | 18 Years - 70 Years | First Affiliated Hospital of Guangxi Medical University | |
| Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus | NCT01600196 | Hepatocellular ... | Liver resection... | 18 Years - 75 Years | Sun Yat-sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
